Archive for the ‘Testing’ Category

Direct Diagnostic Tests for Lyme – the Closest Thing to an Apology You are Ever Going to Get

https://academic.oup.com/cid/advance-article-abstract/doi/10.1093/cid/ciy614/5126199

Abstract

Borrelia burgdorferi was discovered to be the cause of Lyme disease in 1983, leading to seroassays. The 1994 serodiagnostic testing guidelines predated a full understanding of key B. burgdorferi antigens and have a number of shortcomings. These serologic tests cannot distinguish active infection, past infection, or reinfection. Reliable direct-detection methods for active B. burgdorferi infection have been lacking in the past but are needed and appear achievable. New approaches have effectively been applied to other emerging infections and show promise in direct detection of B. burgdorferi infections.
___________________
**Comment**Key quote:  “These serologic tests cannot distinguish active infection, past infection, or reinfection.”

In plain English, these tests don’t show squat.

Yet, my friends, these very useless tests have been used from the beginning to deny treatment to extremely sick people.  “It’s all in your head.  Here’s a anti-depressant.”  “Go, and be well.”  

Lyme patients and the doctors who dare treat them have been shouting this for decades, so the reason for this admission, and it is an admission, is that something’s in the pipeline that they think is going to appease us, and in fact, right after this post, I’m going to post another article that in fact gives the details on this “New direct detection” test.

 The only problem is, direct detection is nothing new.

Dr. Sin Hang Lee has sued the CDC over their suppression of HIS direct detection test.  https://madisonarealymesupportgroup.com/2018/08/15/milford-pathologist-fires-broadside-at-cdc-motion-to-discuss/

Another great article showing how they’ve worked tirelessly to suppress direct detection tests:  https://madisonarealymesupportgroup.com/2018/04/03/cdc-deliberately-avoids-direct-detection-testing-methods-for-ld/

Rewind time a little more and you will learn that Lida Mattman with her collegue JoAnne Whittacker did groundbreaking work on Lyme testing. Their Gold Standard Culture Method has disappeared thanks to the concerted suppression on microscopy.  https://madisonarealymesupportgroup.com/2019/04/02/transmission-of-lyme-disease-lida-mattman-phd/

According to Dr. Shaller, Bowen Research & Training Institute, Inc., is conducting ongoing research using the Bowen Q-RIBb (Quantitative Rapid Identification of Borrelia burgdorferi) test developed by Dr. JoAnne Whitaker. Due to lack of funding, the institute went from a CLIA lab to a research facility.

Bowen research has found the Bb antigen in whole blood, breast milk, urine, placental tissue, semen, eye fluid, teeth, foot nodules, shoulder fluid, spinal fluid, finger joint fluid, and African dust. Findings are documented with digital photography using Darkfield microscopy. The Bowen Lab receives blood specimens for Borrelia burgdorferi (Bb) from forty-six states, including Alaska and Hawaii. In addition, the Bowen lab receives blood from doctors ordering the test from Canada, Brazil, Denmark, Scotland, The Netherlands, Ireland, England, France, Spain, Germany, Switzerland, and the Canary Islands. The recent database numbers for those tested is approximately 6,000. According to a recent poll of patients clinically diagnosed with Lyme disease whose physicians had ordered the Bowen Q-RIBb test, 100% of those patients tested with the Bowen reported their tests were positive for Bb.  https://www.personalconsult.com/articles/bowenresearch.html

Here’s the thing, though, testing is NOT the end all with Lyme/MSIDS. Not even THIS new test.  If anyone is expecting the perfect test, to my knowledge none exists due to all the variables at play including but not limited to how long you’ve been infected and what other pathogens are at play.  The best approach at this point is STILL to go to a knowledgable, educated, experienced practitioner who understands this beast clinically and can diagnose and treat CLINICALLY.

 

Nothing about this beast is easy or straight forward.  Frankly, it doesn’t fit into the Western Medicine paradigm and it never will.  My first appointment with a LLMD was 90 minutes.  90 MINUTES!  Prior to that appointment I filled out a veritable encyclopedia’s worth of medical history dating back to infancy!  Since you can contract Lyme and numerous coinfections congenitally, it very well may be the reason for many peoples’ ill health that they’ve coped with for decades thinking it 1,000 different things.  https://madisonarealymesupportgroup.com/2018/06/19/33-years-of-documentation-of-maternal-child-transmission-of-lyme-disease-and-congenital-lyme-borreliosis-a-review/

No, this will never fit into a 10 minute Western Medicine paradigm.
 

Babesia Found in Patient With Persistent Symptoms Following Lyme Treatment

https://www.ncbi.nlm.nih.gov/m/pubmed/30262525/

Diagnosis of a tick-borne coinfection in a patient with persistent symptoms following treatment for Lyme disease.

Hoversten K, et al. BMJ Case Rep. 2018.

Abstract

A 67-year-old woman presented with 5 days of myalgias and fevers on completion of a 21-day course of amoxicillin for Lyme disease (Borrelia burgdorferi infection). She was found to have profound thrombocytopenia, as well as new anaemia and leucopenia. Workup revealed Babesia microti as the causative agent of her symptoms. The patient quickly improved after appropriate antimicrobial therapy directed against babesiosis was started. This case illustrates the importance of basic microbiology, including epidemiology and common vectors, when creating a differential diagnosis. Because the Ixodes scapularis tick can harbour and transmit multiple parasites simultaneously, the possibility of coinfection should be considered in any patient not responding to appropriate initial medical therapy.

________________

**Comment**

Expect a lot more articles like this.  

Word is finally getting out that Lyme is just the Rock Star we all know by name but there are a lot of wanna be’s right behind him that haven’t made the news.  Research still hasn’t been done showing the synergistic effects of all of this together on the human body.  

To date, ticks can transmit 18 and counting pathogens – ALL as devastating as Lyme:  https://madisonarealymesupportgroup.com/2017/07/01/one-tick-bite-could-put-you-at-risk-for-at-least-6-different-diseases/

Lyme alone is a formidable foe that shape shifts to avoid treatment and the immune system that persists for many despite treatment.

Throw in Babesia, Bartonella, Mycoplasma, viruses, Nematodes (parasitic worms), and stuff not even named yet and a scary but telling picture begins to emerge.

More on Babesia:  https://madisonarealymesupportgroup.com/2016/01/16/babesia-treatment/

Please note that Dr. Horowitiz, a prominent Lyme literate doctor (LLMD) recommends 9 months to a year of solid treatment for Babesia.  He’s finding it to be particularly tenacious.

https://madisonarealymesupportgroup.com/2018/06/08/two-cases-of-babesia/  (They typically blame “severe” cases on a compromised immune system like a missing spleen but here we see someone as healthy as a horse all of a sudden develop shock and near respiratory failure).  If you have Lyme & Babesia &/or any other coinfection, your immune system is severely compromised.

https://madisonarealymesupportgroup.com/2018/07/02/splenic-rupture-from-babesiosis-an-emerging-concern-a-systematic-review-of-current-literature/

https://madisonarealymesupportgroup.com/2018/02/20/babesia-and-heart-issues/

https://madisonarealymesupportgroup.com/2018/10/06/case-of-recurrent-fever-multiple-splenic-infarcts-why-short-treatment-duration-often-doesnt-work-for-babesia/

https://madisonarealymesupportgroup.com/2018/06/03/heart-problems-tick-borne-disease/

https://madisonarealymesupportgroup.com/2018/05/31/widespread-babesiosis-in-canada/

https://madisonarealymesupportgroup.com/2018/03/22/what-is-air-hunger-anyway/

Updates and News From Russell Labs – Wisconsin

http://labs.russell.wisc.edu/wisconsin-ticks/

Updates

August, 2018: Nymphal deer ticks are less abundant but still active in Wisconsin right now. About 20-25% of nymphs are infected with the Lyme spirochete. Overall, 2018 has been normal in terms of tick numbers.

Live in Wisconsin and want your tick identified?

 

Take a picture of ticks on your phone and go here:  https://uwmadison.co1.qualtrics.com/jfe/form/SV_3s1wBopYCcW0lzT

Wisconsin ticks:  http://labs.russell.wisc.edu/wisconsin-ticks/

Go to link for pictures and information on each.  There are 4 ticks listed including the Lone Star Tick, which was until recently considered a Southern tick but is here as well.  Wisconsin had its first RMSF death, transmitted by the Lone Star Tick, recently:  https://madisonarealymesupportgroup.com/2018/07/10/first-rmsf-death-in-wisconsin/

There is also a tab titled “Tick-Borne Diseases.”  Go to link to read about them.  They give WI stats as well.  Please remember ALL the numbers are low as many go unreported:

  • Lyme (Bb or Bm)
  • Borrelia miyamotoi (relapsing fever)
  • Anasplasmosis
  • Ehrlichia muris eauclairensis (EML)
  • Babesiosis
  • Powassan virus/deertick virus
  • Ehrlichia chaffeensis
  • Rocky Mountain Spotted Fever

__________________

A few points stick out to me:

  1. Please take pictures of these ticks & send them in so we finally have an accurate record.  They are asking us for help so let’s give it.  It will only help us in the end.  Flood them with ticks!
  2. Baronella didn’t make the list, yet nearly everyone I work with has it.  WHY?  Because while Bart has been found in ticks, it hasn’t been proven conclusively they transmit.  Bart is a nasty, nasty bug and alone can kill you.  Coupled with Lyme it can make you want to die.
  3. For viruses, they only list Powassan when many more are on record including Heartland and Bourbon (unfortunately they aren’t mandatory to report).  They know Heartland is transmitted by the Lone Star tick but I couldn’t even find the tick supposedly responsible for Bourbon, although it’s a killer:  https://madisonarealymesupportgroup.com/2017/07/01/one-tick-bite-could-put-you-at-risk-for-at-least-6-different-diseases/
  4. The lack of data is glaring.  Seriously.  Glaring.  Zika makes front page news here and our mosquitoes can’t even carry it.  https://madisonarealymesupportgroup.com/2018/03/13/wed-nite-the-lab-talk-on-mosquitoes-ticks-disease/  There were only 46 cases of Zika in the U.S. in 2018 – ALL due to travelers returning from affected areas.The CDC “estimates” that there are 300,000 NEW Lyme Disease cases annually in the U.S.  Anyone see a disparity here between Zika and Lyme?  (Other tick-borne diseases aren’t even on the radar yet)

 

 

 

 

 

 

 

 

Bb Found in Brazilian Primates for the 1st Time

http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0036-46652018005000704&lng=en&nrm=iso&tlng=en

Rev. Inst. Med. trop. S. Paulo vol.60  São Paulo  2018  Epub Sep 13, 2018

http://dx.doi.org/10.1590/s1678-9946201860053

Letter to the Editor

Molecular detection of Borrelia burgdorferi in free-living golden headed lion tamarins (Leontopithecus chrysomelas) in Rio de Janeiro, Brazil

Aline Vieira Pinheiro dos Santos1  Aline Moreira de Souza1  Marina Galvão Bueno2  3  José Luiz Catao-Dias4  Helena Keiko Toma5  Alcides Pissinati4  6  Camila Vieira Molina2  Maria Cecília Martins Kierulff2  7  Danilo Gomes Freitas Silva2  4  Nádia Regina Pereira Almosny1 

 

Borreliosis is an infectious disease caused by Borrelia spirochetes, transmitted mainly by Ixodes ricinus ticks1 to animals or humans2. The known Borrelia species determine five distinct disease groups: human recurrent fever, avian borreliosis, bovine borreliosis, Lyme borreliosis and bovine scrapie3–6. Lyme disease (LD) is a multisystem disease with a wide geographical distribution and has B. burgdorferi as the main agent in several continents5,7.

In Brazil, borreliosis is called Brazilian Lyme-like disease, Baggio-Yoshinari Syndrome or Brazilian Borreliosis (BB), is transmitted by ticks that are not from the Ixodes ricinus complex, and is caused by B. burgdorferi sensu lato8.

Borrelia species were described in non-human primates that currently serve as an experimental model for Lyme disease2,9–11.

Borrelia species are transmitted primarily by ticks, but in rare cases or experimentally, they can be transmitted by tabanids, culicides and siphonapters12. Studies on borreliosis have been carried out to compare immunological, histopathological and clinical responses of animals and humans infected with Borrelia burgdorferi. In these studies, animals were inoculated or exposed to the Ixodides dammini tick1,9,11, and findings such as conjunctivitis, rash, deep perivascular lymphocytic infiltration that are characteristic in humans1, a large amount of spirochetes in nervous tissue of immunosuppressed animals9 and spirochetes in cardiac tissue10 were reported.

In order to identify arthropod-borne pathogens in an exotic invasive population of Leontopithecus chrysomelas (golden-headed lion tamarin), that inhabit Serra da Tiririca State Park (PESET), an urban Atlantic Rainforest area in Niteroi (Rio de Janeiro, Brazil), to translocate them to their native area (Bahia, Brazil), blood samples were analyzed. PESET harbor a large diversity of endemic fauna and flora and is considered an important ecotourism area. Inappropriate housing constructions, the increase of human and animal populations living inside the park or in its surroundings, hunting and inadequate garbage disposal have been recently causing damage to the park13.

This study was approved by the Ethics Commission on Animal Use (CEUA) from Universidade Federal Fluminense (process N° 367, issued in 10/10/2013) and was in full compliance with the federal authorizations issued by the Environment Ministry (SISBIO n 30939-4 issued in 18/05/2012). All procedures were also approved by the Committee on Ethics on Animal Research (CEUA) of Veterinary Medicine and Animal Science Faculty of the Universidade de Sao Paulo (Protocol N° 2662/2012 and 7085041215).

Blood samples of 200 L. chrysomelas, males and females, of different ages and independent of clinical alterations were subjected to DNA extraction using the Illustra blood genomic Prep Mini Spin Kit (GE Healthcare Life Sciences, Sao Paulo, Brazil), according to the manufacturer instructions. Extracted DNA was then used as the template DNA in B. burgdorferi sensu lato (s.l.) amplifications. Nested Polymerase Chain Reaction (n-PCR) assay using primer 5Bor-out (5′-GTCAAACGGGATGTAGCAA TAC-3′) and 3Bor-out (5′-CACACTTAACACGTTAGCTTCG-3′), followed by a second reaction with primer 5Bor-in (5′-ATTCAGTGGCGAACGGGTG-3′) and 3Bor-in (5′-AACAACGCTCGCCCCTTAC-3′), which amplifies a fragment of 811 bp/ 469 bp of the 16S rRNA gene of B. burgdorferi sensu lato, were performed.

A total of 16% (32/200) L. chrysomelas were positive to B. burgdorferi by n-PCR. Sequencing of five positive samples showed 99% of similarity with B. burgdorferi sequences available in GenBank. This was the first time that borreliosis is found in non- human primates in Brazil.

Borrelia infection in humans was first described in Brazil in 1992, and has an increasing number of suspect cases, differing from LD due to the recurrence rate after treatment and the intense immune response8. The presence of Borrelia burgdorferi in free-living golden-headed lion tamarins that inhabit Atlantic Forest biome of Rio de Janeiro, Brazil, confirms that this spirochete is circulating in this region and suggests that these small primates may play a role in transmission of this pathogen to other animals or human beings. Veterinarians and medical doctors should consider this zoonotic pathogen in their diagnostic routine.

Further studies are needed, including sequencing of all positive samples, in order to compare these small primates positive sequences with those of humans and other animals in study area.

REFERENCES

1. Philipp MT, Aydintug MK, Bohm RP Jr, Cogswell FB, Dennis VA, Lanners HN, et al. Early and early disseminated phases of Lyme disease in the rhesus monkey: a model for infection in humans. Infect Immun. 1993;61:3047-59. [ Links ]

2. Soares CO, Ishikawa MM, Fonseca AH, Yoshinari NH. Borrelioses, agentes e vetores. Pesq Vet Bras. 2000;20:1-19. [ Links ]

3. Babour AG, Hayes SF. Biology of Borrelia species. Microbiol Rev. 1986;50:381-400. [ Links ]

4. Quinn PJ, Carter ME, Markey BK, Carter GR. Clinical veterinary microbiology. London: Wolfe; 1994. [ Links ]

5. Wang G, van Dam AP, Le Fleche A, Postic D, Peter O, Baranton G, et al. Genetic and phenotypic analysis of Borrelia valaisiana sp. nov. (Borrelia genomic groups VS116 and M19). Int J Syst Bacteriol. 1997;47:926-32. [ Links ]

6. Zingg BC, LeFebvre RB. Polymerase chain reaction for detection of Borrelia coriaceae, putative agent of epizootic bovine abortion. Am J Vet Res. 1994;55:1509-15. [ Links ]

7. Bennett CE. Ticks and Lyme diseases. Adv Parasitol. 1995;36:343-405. [ Links ]

8. Basile RC, Yoshinari NH, Mantovani E, Bonoldi VN, Macoris DG, Queiroz-Neto A. Brazilian borreliosis with special emphasis on humans and horses. Braz J Microbiol. 2017;48:167-72. [ Links ]

9. Cadavid D, O’Neill T, Schaefer H, Pachner R. Localization of Borrelia burgdorferi in the nervous system and other organs in a nonhuman primate model of Lyme disease. Lab Invest. 2000;80:1043-54. [ Links ]

10. Cadavid D, Bai Y, Hodzic E, Narayan K, Barthold SW, Pachner AR. Cardiac involvement in non-human primates infected with the Lyme disease spirochete Borrelia burgdorferi. Lab Invest. 2004;84:1439-50. [ Links ]

11. Roberts ED, Bohm RP Jr, Lowrie RC, Habicht G, Katona L, Piesman J, et al. Pathogenesis of Lyme neuroborreliosis in the rhesus monkey: the early disseminated and chronic phases of disease in the peripheral nervous system. J Infect Dis. 1998;178:722-32. [ Links ]

12. Alvim NC, Bento MA, Martins LA. Borreliose de Lyme: a doença da década. Rev Cient Eletr Med Vet. 2005;4. [ Links ]

13. Instituto Estadual do Ambiente. Resumo executivo: plano de manejo: Parque Estadual da Serra da Tiririca – PESET. Rio de Janeiro: INEA; 2012. [ Links ]

Received: August 13, 2018; Accepted: August 16, 2018

 

Relapsing Fever Borrelia in California: a Pilot Serological Study

https://doi.org/10.2147/IJGM.S176493 https://doi.org/10.2147/IJGM.S176493

Relapsing fever Borrelia in California: a pilot serological study

Middelveen MJ, Shah JS, Fesler MC, Stricker RB.

International Journal of General Medicine 2018 Sep 21;11:373-382. eCollection 2018.

Abstract

Background

Borrelia spirochetes are tick-borne Gram-negative bacteria that cause disease in humans and animals. Although many studies have focused on Borrelia burgdorferi (Bb), the agent of Lyme disease, recent studies have examined the role of Relapsing Fever Borrelia (RFB) in human disease. In this pilot study, we have evaluated serological reactivity against Bb and RFB in patients residing in California.

Methods

Serological testing for reactivity to Bb and RFB antigens was performed in 543 patients with suspected tick-borne illness using a Western blot technique. Further evaluation of a subset of 321 patients residing in California was obtained. Serum samples were tested for IgM and IgG antibodies reactive with Bb and RFB, and samples were classified by county of residence according to Bb reactivity alone, RFB reactivity alone, and dual reactivity against Bb and RFB. Seroreactivity was ranked in counties with the highest absolute number and the highest prevalence of positive samples.

Results

Of the 543 total serum samples, 32% were positive for Bb, 22% were positive for RFB, and 7% were positive for both Bb and RFB. Of the 321 serum samples from patients residing in California, 33% were positive for Bb, 27% were positive for RFB, and 11% were positive for both Bb and RFB. In the California cohort, the highest rates of positive serological testing for Bb were found in Santa Clara, Alameda, and Contra Costa counties, while the highest rates of positive serological testing for RFB were found in Santa Clara, Alameda, Marin, and San Francisco counties. The highest rates of dual reactivity against Bb and RFB were found in Contra Costa, Alameda, and San Francisco counties. Among the 24 counties with patients who were tested, Bb seropositivity alone was found in four counties, RFB seropositivity alone was found in two counties, and seropositivity for both Bb and RFB was found in 14 counties.

Conclusion

Results of this pilot study suggest that seroreactivity against Bb and RFB is widespread in California, and dual exposure to Bb and RFB may complicate the diagnosis of tick-borne disease. Greater awareness of RFB and broader screening for this tick-borne infection is warranted.

__________________

**Comment**

Recently it was discovered that that new relapsing fever like genomes have links to the Lyme disease borrelia.  Guess patients haven’t been making this up after all:  https://madisonarealymesupportgroup.com/2018/10/04/new-relapsing-fever-like-genomes-found-with-links-to-lyme-disease-borrelia/

California patients, similarly to Southern patients, have been told for decades they can’t have Lyme, because it doesn’t exist in their neck of the woods.

That was baloney then and it’s baloney now.
Time to start listening to patients who have far better things to do than fake illness.

https://www.lymedisease.org/relapsing-fever-calif/  (Video abstract of research article in link)  This article states that Relapsing Fever Borrelia (RFB) was thought to only be in Europe and the East Coast of the U.S.  This again demonstrates patients who are complaining of “Lyme-like” symptoms are truly infected with tick borne pathogens of one sort or another.  The one-drug, one-pathogen paradigm does not work with these patients.  Approved FDA testing BTW, doesn’t even exist for RFB.

“A negative Lyme test does not rule out the possibility of infection with Relapsing Fever Borrelia, and clinicians should be familiar with disease presentation and available diagnostic tests.”  Melissa Fesler, nurse practitioner

“Tick-borne Relapsing Fever is the next wave of Lyme disease,” says Stricker. “It’s not just a simple disease anymore.”

This again, demonstrates the importance of being educated on ALL TBI’s, and understanding that ALL TBI diagnosis is clinical.  Testing is abysmal.

For more on California and tick borne illness:  https://madisonarealymesupportgroup.com/2018/06/23/say-what-california-fifth-in-nation-for-lyme-insurance-claims/

https://madisonarealymesupportgroup.com/2018/05/19/infected-ticks-in-california-its-complicated/

https://madisonarealymesupportgroup.com/2017/08/07/california-lyme-cases-get-no-respect/

https://madisonarealymesupportgroup.com/2018/02/02/miyamotoi-in-ixodes-pacificus-in-california/

https://madisonarealymesupportgroup.com/2018/02/15/b-miyamotoi-in-ca-ticks-for-a-long-time/

https://madisonarealymesupportgroup.com/2018/02/14/borrelia-miyamotoi-in-ca-serodiagnosis-is-complicated-by-multiple-endemic-borrelia-species/

https://madisonarealymesupportgroup.com/2017/10/09/bb-in-california-chipmunk-and-squirrels/

https://madisonarealymesupportgroup.com/2011/09/25/putting-lyme-behind-you-questions-and-answers-with-california-lyme-doctors/

For interested practitioners on HOW to become educated:  https://madisonarealymesupportgroup.com/2018/06/06/lyme-education-for-healthcare-professionals/